tradingkey.logo
tradingkey.logo
Search

Astrazeneca Says CHMP Recommends Calquence-Based Regimens For Approval In EU

ReutersApr 29, 2025 6:25 AM
facebooktwitterlinkedin

- AstraZeneca PLC AZN.L:

  • FIXED-DURATION CALQUENCE RECOMMENDED IN EU FOR CLL

  • CHMP RECOMMENDS CALQUENCE-BASED REGIMENS FOR APPROVAL IN EU

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI